Quantum-enhanced nanodiamond rapid test advances early SARS-CoV-2 antigen detection in clinical diagnostics

Alyssa Thomas DeCruz; Benjamin S. Miller; Da Huang; Max McRobbie; Felix Donaldson; Laura E. McCoy; Ciara K. O’Sullivan; Johannes C. Botha; Eleni Nastouli; Rachel A. McKendry

doi:10.1038/s41467-025-63066-1

Quantum-enhanced nanodiamond rapid test advances early SARS-CoV-2 antigen detection in clinical diagnostics

Alyssa Thomas DeCruz, Benjamin S. Miller, Da Huang, Max McRobbie, Felix Donaldson, Laura E. McCoy, Ciara K. O’Sullivan, Johannes C. Botha, Eleni Nastouli, Rachel A. McKendry

2025Nature Communications 16, 8778CC BY 4.0LCP000075

Fig. 4, panel (c)

Panel (c): estimated percentage of patients detected positive by the FND (blue) and AuNP (teal) assays on days 0 to 6 since symptom onset (Frediani et al. Ct distribution). The proportions of patients with Ct $\leq$ 25, 25 to 30 and above 30, drawn as grey areas in the print, are in the data but not drawn.

Files

Data: data.csv

Provenance

This panel was computed from the authors' public data deposit (Nature Communications Source Data: https://doi.org/10.1038/s41467-025-63066-1, CC BY 4.0). The plot shown here is re-rendered for interactive viewing and analysis. See the paper for the original figure and full scientific context.

License: CC BY 4.0.

Nat. Commun. 16, 8778 (2025) · DOI: 10.1038/s41467-025-63066-1

Other panels of Fig. 4: (a) (b-1) (b-2)

All figures of this paper

All papers · About · Statistics · Submit data · API